Items where authors include "Spencer, A"

Article

Price, S, Landa, P, Mujica-Mota, R orcid.org/0000-0002-7430-2744 et al. (2 more authors) (2023) Revising the suspected-cancer guidelines: Impacts on patients' primary care contacts and costs. Value in Health, 26 (7). pp. 995-1002. ISSN 1098-3015

Thompson, MA, Boccadoro, M, Leleu, X et al. (26 more authors) (2023) Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients. Clinical Lymphoma Myeloma and Leukemia, 23 (3). e171-e181. ISSN 2152-2650

Hájek, R, Minařík, J, Straub, J et al. (33 more authors) (2021) Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myeloma. Future Oncology. fon-2020-1225. ISSN 1479-6694

Price, S, Spencer, A, Zhang, X et al. (6 more authors) (2020) Trends in time to cancer diagnosis around the period of changing national guidance on referral of symptomatic patients: A serial cross-sectional study using UK electronic healthcare records from 2006–17. Cancer Epidemiology, 69. 101805. ISSN 1877-7821

Mújica‐Mota, RE, Landa, P, Pitt, M et al. (2 more authors) (2020) The heterogeneous causal effects of neonatal care: a model of endogenous demand for multiple treatment options based on geographical access to care. Health Economics, 29 (1). pp. 46-60. ISSN 1057-9230

Mateos, M-V, Spencer, A, Nooka, AK et al. (16 more authors) (2019) Daratumumab-Based Regimens Are Highly Effective And Well Tolerated In Relapsed Or Refractory Multiple Myeloma Regardless Of Patient Age: Subgroup Analysis Of The Phase 3 CASTOR And POLLUX Studies. Haematologica. ISSN 0390-6078

Walter, FM, Thompson, MJ, Wellwood, I et al. (12 more authors) (2019) Evaluating diagnostic strategies for early detection of cancer: the CanTest framework. BMC CANCER, 19. ARTN 586. ISSN 1471-2407

Spencer, A, Tomeny, E, Mujica-Mota, RE orcid.org/0000-0002-7430-2744 et al. (3 more authors) (2019) Do time trade-off values fully capture attitudes that are relevant to health-related choices? The European Journal of Health Economics, 20 (4). pp. 559-568. ISSN 1618-7598

Costello, C, Davies, FE, Cook, G orcid.org/0000-0003-0223-3652 et al. (16 more authors) (2019) INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myeloma. Future Oncology, 15 (13). pp. 1411-1428. ISSN 1479-6694

Dimopoulos, MA, Gay, F, Schjesvold, F et al. (24 more authors) (2019) Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial. The Lancet, 393 (10168). pp. 253-264. ISSN 0140-6736

Gay, F, Jackson, G, Rosiñol, L et al. (28 more authors) (2018) Maintenance Treatment and Survival in Patients With Myeloma: A Systematic Review and Network Meta-analysis. JAMA Oncology, 4 (10). pp. 1389-1397. ISSN 2374-2437

Shepherd, AI, Pulsford, R, Poltawski, L et al. (9 more authors) (2018) Physical activity, sleep, and fatigue in community dwelling Stroke Survivors. Scientific Reports, 8. 7900. ISSN 2045-2322

Dean, SG, Poltawski, L, Forster, A orcid.org/0000-0001-7466-4414 et al. (11 more authors) (2018) Community-based rehabilitation training after stroke: results of a pilot randomised controlled trial (ReTrain) investigating acceptability and feasibility. BMJ Open, 8 (2). e018409. ISSN 2044-6055

Dean, SG, Poltawski, L, Forster, A orcid.org/0000-0001-7466-4414 et al. (8 more authors) (2016) Community-based Rehabilitation Training after stroke: Protocol of a pilot randomised controlled trial (ReTrain). BMJ Open, 6 (10). e012375.